Clinical trials
Prospective Study clinical trials
Below are recruiting prospective study clinical trials, each written for real people, not researchers. We’re tracking 867 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07644013Recruiting
Multiple System Atrophy Registry Study in China
This study is collecting information from patients with multiple system atrophy (a rare neurological condition affecting movement and body functions), Parkinson disease, and healthy volunteers to better understand these conditions. By participating, you help doctors learn more about how these diseases develop and progress.
Beijing, Beijing MunicipalityAges 40–75 - NCT07636824RecruitingPhase 2
Chemotherapy plus radiation after bile duct cancer surgery
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
BeijingAges 18–80 - NCT07624968Recruiting
Breastfeeding and diabetes risk in future pregnancies
This study follows pregnant women to see if breastfeeding while pregnant with a previous child helps protect against gestational diabetes (high blood sugar during pregnancy) in the current pregnancy. Researchers will track blood sugar levels and ultrasound measurements throughout pregnancy.
IstanbulAges 18–50 - NCT06183892Recruiting
Extended-release tacrolimus in stable child liver transplant recipients
This study tests an extended-release version of the anti-rejection drug tacrolimus in children who have already had a stable liver transplant. The goal is to see if the longer-acting capsule works as well as the immediate-release form, potentially simplifying daily medication routines.
ShanghaiAges 6 months–18 years - NCT07558590Recruiting
Shoulder Replacement System Recovery and Function Study
This study follows patients who have received a new shoulder replacement device to see how well it works and how patients recover. Researchers will collect information about your shoulder function and satisfaction over time.
AmiensAges 18 years+ - NCT07547618Recruiting
Pain Management in Recovery Room After Surgery
This study observes how much pain medication patients need right after surgery while they're in the recovery room. Researchers want to understand pain patterns to help improve comfort for future surgical patients.
Ankara, YenimahalleAges 18 years+ - NCT07539792RecruitingPhase 2
New Skull Support Plates for Pituitary Tumor Surgery
This study tests a new type of absorbable (dissolvable) support plate used during minimally invasive surgery to remove tumors in the pituitary gland area. The plate helps support the surgical site as it heals. Researchers want to see if this new plate works safely and effectively compared to standard approaches.
Foshan, GuangdongAges 1–80 - NCT07535385Recruiting
Kidney Artery Blocking Treatment for Polycystic Kidney Disease
This study follows patients with a genetic kidney disease (autosomal dominant polycystic kidney disease) who are on dialysis and receive a procedure to block blood flow to their enlarged kidneys. Researchers will track how well the procedure works and how it affects patients over time using imaging scans.
Pavia, LombardyAges 18–75 - NCT07532915Recruiting
Two endoscopy methods to prevent stomach vein bleeding
This trial compares two endoscopic (camera-guided) procedures to prevent or treat bleeding from enlarged veins in the stomach. Both approaches aim to stop dangerous bleeding or prevent it from happening in high-risk patients.
Guangzhou, GuangdongAges 18–80 - NCT06771011Recruiting
Comparing two ways to diagnose liver injury causes
This study compares two methods (RUCAM and RECAM) to better identify what caused a recent liver injury. It may help doctors find the right cause and treatment faster.
Beijing, Beijing MunicipalityAges 18–85 - NCT04701047Recruiting
Study of symptoms in vaginal prolapse patients
This is an observational study that follows women with vaginal prolapse to better understand symptoms and patient experiences. It may help improve future care, even though it does not test a new treatment.
GhentAges 18 years+ - NCT07485686Enrolling by invitation
Studying urinary tract infections to improve treatment
This study collects medical data from people with urinary tract infections (UTIs) to help future research and improve how UTIs are treated. You may be eligible if you have symptoms of a UTI now or have had them in the past.
FrankfurtAges 18 years+ - NCT06790875Recruiting
Comparing two ventilator settings for lung health in ARDS
This study tests two methods of adjusting a ventilator to see which one may better protect the lungs of patients with ARDS. It will help doctors learn how to set the machine to reduce strain on the lungs.
Wuhan, HubeiAges 18–80 - NCT07388966Recruiting
Measuring limb movement in achondroplasia and hypochondroplasia
This study is tracking how people with achondroplasia or hypochondroplasia move their limbs in daily life using a small wearable device. The information will help doctors better understand these conditions and may lead to better care.
LiègeAges 2–65 - NCT06836492RecruitingPhase 3
Risk-based treatment study for children with rhabdomyosarcoma
This study tests different treatment plans for children with rhabdomyosarcoma based on their individual risk factors. It aims to find the best therapy for each child, potentially improving outcomes.
Guangzhou, GuangdongAges birth–18 years - NCT06839898Recruiting
Study of two implantable astigmatism-correcting lenses
This study tests two types of implantable lenses that correct astigmatism (blurry vision from an irregularly shaped cornea). You keep your own natural lens, and the new lens is placed in front of it—no laser or lens removal needed. The goal is to see which lens works better and is safer.
Münster, North Rhine-WestphaliaAges 21 years+ - NCT07348575Enrolling by invitationPhase 3
Decitabine plus R-CHOP for EBV-positive DLBCL
This trial tests whether adding a drug called decitabine to the standard chemo-immunotherapy R-CHOP can help people with a specific type of lymphoma (DLBCL that is positive for EBV) who have not been treated before. The goal is to see if the combination works better than R-CHOP alone.
Nanchang, JiangxiAges 18–75 - NCT07300449RecruitingPhase 2
Predicting chemo response in children with hepatoblastoma
This trial tests a new way to see if chemotherapy will work for children with hepatoblastoma, a type of liver cancer. It uses a blood test (ctDNA 5hmc) to help predict treatment success and monitor if the cancer comes back.
Guangzhou, GuangdongAges Up to 18 years - NCT07294547Recruiting
Comparing two antivirals for kidney transplant patients
This trial compares two antiviral drugs, valacyclovir and valganciclovir, to see if valacyclovir works as well as valganciclovir for preventing CMV and EBV infections after a kidney transplant.
TaipeiAges 3 years+ - NCT07287241Recruiting
Heart health study for people with osteogenesis imperfecta
This study looks at heart structure and function in children and adults with osteogenesis imperfecta (OI), a condition that affects bones. Researchers want to understand how OI may impact the heart.
Bologna, Emilia-RomagnaAges 5–80 - NCT06891144Recruiting
Study of older adults with AML getting intensive treatment
This study follows people aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who are receiving strong chemotherapy. It aims to learn more about their health outcomes and better understand the disease in this age group.
AngersAges 60 years+ - NCT07251114Recruiting
AI help for early esophageal cancer depth check during endoscopy
This trial tests if artificial intelligence can help doctors more accurately determine how deep early esophageal cancer goes during an endoscopic ultrasound. It may lead to better treatment decisions for people with early signs of esophageal cancer.
Fuzhou, FujianAges 18 years+ - NCT07253129Recruiting
Stem cell transplant study for T-cell lymphoma patients with partial response
This study compares two types of stem cell transplants (from a donor or your own cells) for people with certain T-cell lymphomas who had only a partial response to first chemotherapy. It aims to see which approach may work better.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07255378Recruiting
Vasopressin for septic shock in the ICU
This study observes how the medication vasopressin works when added to standard treatment for septic shock in the ICU. It helps doctors understand if vasopressin improves outcomes for patients with severe infection and low blood pressure.
Terrassa, BARCELONAAges 18 years+
Hear when a new Prospective Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prospective study?
- Yes. Clin2 currently lists 867 recruiting prospective study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prospective study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prospective study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.